Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.83 |
| ▸ | NPC1 | O15118 | 3/20 | 0.63 |
| ▸ | RAB9A | P51151 | 3/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.63 |
| ▸ | RELA | Q04206 | 1/20 | 0.62 |
| ▸ | CA12 | O43570 | 1/20 | 0.61 |
| ▸ | CA1 | P00915 | 1/20 | 0.61 |
| ▸ | CA2 | P00918 | 1/20 | 0.61 |
| ▸ | CA7 | P43166 | 1/20 | 0.61 |
| ▸ | CA9 | Q16790 | 1/20 | 0.61 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.61 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | CASP3 | P42574 | 1/20 | 0.54 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.54 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL295716 | 1.00 | ACHE (0.83) | ACHENPC1RAB9AKMT2ARELA | |
| SCHEMBL12714843 | 1.00 | ACHE (0.83) | ACHENPC1RAB9AKMT2ARELA | |
| Hydrazine SCHEMBL27971879 | 0.95 | ACHE (0.75) | ACHENPC1RAB9AKMT2ARELA | |
| SCHEMBL12276818 | 0.93 | ACHE (0.71) | ACHENPC1RAB9AKMT2ARELA | |
| SCHEMBL12334794 | 0.93 | ACHE (0.71) | ACHENPC1RAB9AKMT2ARELA | |
| SCHEMBL12761860 | 0.93 | ACHE (0.71) | ACHENPC1RAB9AKMT2ARELA | |
| SCHEMBL12770835 | 0.93 | ACHE (0.71) | ACHENPC1RAB9AKMT2ARELA | |
| SCHEMBL12335539 | 0.93 | ACHE (0.71) | ACHENPC1RAB9AKMT2ARELA | |
| SCHEMBL18708707 | 0.93 | ACHE (0.71) | ACHENPC1RAB9AKMT2ARELA | |
| SCHEMBL14826485 | 0.93 | ACHE (0.71) | ACHENPC1RAB9AKMT2ARELA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230150919-A1 | Method for Producing Mono-Cross-Coupled Aromatic Compound Having Leaving Group | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2023-05-18 | — | — | US | disclosed |
| US-20220216422-A1 | Electroluminescent Device | UDC IRELAND LTD (IE) | 2022-07-07 | — | — | US | disclosed |
| US-11332670-B2 | Side-chain liquid crystal polymer, liquid crystal composition, retardation film, method for producing retardation film, transfer laminate, optical member, method for producing optical member, and display device | DAI NIPPON PRINTING CO., LTD. (JP) | 2022-05-17 | — | — | US | disclosed |
| US-20190136134-A1 | SIDE-CHAIN LIQUID CRYSTAL POLYMER, LIQUID CRYSTAL COMPOSITION, RETARDATION FILM, METHOD FOR PRODUCING RETARDATION FILM, TRANSFER LAMINATE, OPTICAL MEMBER, METHOD FOR PRODUCING OPTICAL MEMBER, AND DISPLAY DEVICE | DAI NIPPON PRINTING CO., LTD. (JP) | 2019-05-09 | — | — | US | disclosed |
| US-9923148-B2 | Electroluminescent device | UDC IRELAND LIMITED (IE) | 2018-03-20 | — | — | US | disclosed |
| US-20170194568-A9 | Electroluminescent Device | UDC IRELAND LIMITED (IE) | 2017-07-06 | — | — | US | disclosed |
| US-20130079517-A1 | Electroluminescent Device | BASF SE (DE) | 2013-03-28 | — | — | US | disclosed |
| US-8012602-B2 | Blue emitting, durable, organoelectroluminescent layers containing pyrimidine moieties; full color displays; light emission efficiency and brightness | BASF SE (DE) | 2011-09-06 | — | — | US | disclosed |
| US-7838089-B2 | with biphenylcyclohexane-based skeleton; nematic at room temperature, improved response; paraelectric | SONY CORPORATION (JP) | 2010-11-23 | — | — | US | disclosed |
| US-7838089-B2 | with biphenylcyclohexane-based skeleton; nematic at room temperature, improved response; paraelectric | SONY CORPORATION (JP) | 2010-11-23 | — | — | US | disclosed |
| US-20100240892-A1 | ELECTROLUMINESCENT DEVICE | SCHAEFER THOMAS | 2010-09-23 | — | — | US | disclosed |
| EP-2170396-A1 | DRUG COMBINATIONS FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | BioMarin IGA Limited (BS) | 2010-04-07 | — | — | EP | disclosed |
| US-20090168009-A1 | with biphenylcyclohexane-based skeleton; nematic at room temperature, improved response; paraelectric | SONY CORPORATION (JP) | 2009-07-02 | — | — | US | disclosed |
| US-20090168009-A1 | with biphenylcyclohexane-based skeleton; nematic at room temperature, improved response; paraelectric | SONY CORPORATION (JP) | 2009-07-02 | — | — | US | disclosed |
| US-20090102373-A1 | Electroluminescent device | HAYOZ PASCAL | 2009-04-23 | — | — | US | disclosed |
| WO-2009019504-A1 | DRUG COMBINATIONS FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | SUMMIT CORPORATION PLC (GB) | 2009-02-12 | — | — | WO | disclosed |
| US-20070080628-A1 | Electroluminescent devices comprising 2-(p-triphenyl)-3-phenyl-pyrazine derivatives | CIBA SPECIALTY CHEMICALS CORP. | 2007-04-12 | — | — | US | disclosed |
| US-20070080628-A1 | Electroluminescent devices comprising 2-(p-triphenyl)-3-phenyl-pyrazine derivatives | CIBA SPECIALTY CHEMICALS CORP. | 2007-04-12 | — | — | US | disclosed |
| EP-1687856-B1 | ELECTROLUMINESCENT DEVICES COMPRISING 2-(P-TRIPHENYL)-3-PHENYL-PYRAZINE DERIVATIVES | CIBA SC HOLDING AG (CH) | 2007-02-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230150919-A1 | Method for Producing Mono-Cross-Coupled Aromatic Compound Having Leaving Group | DDC, PAH, ATIC | ACHE 2454/4885NPC1 2885/4885RAB9A 2875/4885 |
| US-20220216422-A1 | Electroluminescent Device | PNPO, ODC1, AXL | ACHE 183/4885NPC1 4737/4885RAB9A 2872/4885 |
| US-20090102373-A1 | Electroluminescent device | TAAR5, TYR, TRPC5 | ACHE 219/4885NPC1 4847/4885RAB9A 3537/4885 |
| US-20170194568-A9 | Electroluminescent Device | DPYD, PNPO, TYMP | ACHE 325/4885NPC1 4733/4885RAB9A 3141/4885 |
| US-20130079517-A1 | Electroluminescent Device | DPYD, PNPO, TYMP | ACHE 325/4885NPC1 4733/4885RAB9A 3141/4885 |
| US-20100240892-A1 | ELECTROLUMINESCENT DEVICE | PNPO, ODC1, AXL | ACHE 183/4885NPC1 4737/4885RAB9A 2872/4885 |
| US-20070080628-A1 | Electroluminescent devices comprising 2-(p-triphenyl)-3-phenyl-pyrazine derivatives | C1S, TYR, C5 | ACHE 1325/4885NPC1 4715/4885RAB9A 3466/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.